Cargando…

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents

OBJECTIVE: To analyze the lipid profile and cardiovascular risk of overweight and obese adolescents and correlate the findings with anthropometric measurements. METHODS: This is a cross-sectional study on overweight and obese adolescents of both sexes (aged 14 to 18 years old). The collected variabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Andrades, Clara dos Santos, Poletti, Victória Volkweis, Closs, Vera Elizabeth, Gustavo, Andreia da Silva, Oliveira, Margareth da Silva, Donadio, Márcio Vinícius Fagundes, Feoli, Ana Maria Pandolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade de Pediatria de São Paulo 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014021/ https://www.ncbi.nlm.nih.gov/pubmed/36921163 http://dx.doi.org/10.1590/1984-0462/2023/41/2021312

Ejemplares similares

Effect of an interdisciplinary intervention with motivational approach on exercise capacity in obese adolescents: a randomized controlled clinical trial
por: Zanatta, Letiane Bueno, et al.
Publicado: (2020)

MAXIMUM HEART RATE MEASURED VERSUS ESTIMATED BY DIFFERENT EQUATIONS DURING THE CARDIOPULMONARY EXERCISE TEST IN OBESE ADOLESCENTS
por: Heinzmann-Filho, João Paulo, et al.
Publicado: (2018)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Lifestyle Intervention on Metabolic Syndrome and its Impact on Quality of Life: A Randomized Controlled Trial
por: Saboya, Patrícia Pozas, et al.
Publicado: (2017)

Dyslipidemia is Associated with Unfit and Overweight-Obese Children and Adolescents
por: Reuter, Cézane Priscila, et al.
Publicado: (2016)

Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review
por: Razzera, Bruno Nunes, et al.
Publicado: (2021)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Alimentary Habits, Physical Activity, and Framingham Global Risk Score in Metabolic Syndrome
por: Soares, Thays Soliman, et al.
Publicado: (2014)

SALIVARY CORTISOL AND METABOLIC SYNDROME COMPONENT’S ASSOCIATION
por: GARBELLOTTO, Grasiane Izidorio, et al.
Publicado: (2018)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
por: Munigoti, Srinivasa P., et al.
Publicado: (2014)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Respiratory muscle strength test: is it realistic in young children?
por: Heinzmann-Filho, João Paulo, et al.
Publicado: (2015)

Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
por: Feinman, Richard D, et al.
Publicado: (2006)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2018)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs
por: Romandini, Alessandra, et al.
Publicado: (2023)

Association between Wakeup Frequency at Night and Atherogenic Dyslipidemia: Evidence for Sex Differences
por: Yao, Chien-An, et al.
Publicado: (2023)

FUNCTIONAL PERFORMANCE IN THE MODIFIED SHUTTLE TEST IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
por: Leite, Luanna Rodrigues, et al.
Publicado: (2020)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
por: Lechner, Katharina, et al.
Publicado: (2020)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
por: Roy, Probin Kr, et al.
Publicado: (2023)

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
por: Butnariu, Lăcramioara Ionela, et al.
Publicado: (2023)

Scoring tools to monitor risk of disease progression in patients with cystic fibrosis
por: Donadio, Márcio Vinícius Fagundes, et al.
Publicado: (2020)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

Dyslipidemia in Iranian overweight and obese children
por: Ghergerehchi, Robabeh
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_la4jpc8ru3h9og6eq3m2n1fikv